Compared with clear cell RCC, the positive rate of AR in Xp11.2 tRCC tissues was higher, and its expression was negatively associated with the progression‐free survival of Xp11.2 tRCC. The gene discussed is AR; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.